Modra
Phase I results with ModraDoc006/r published in the European Journal of Cancer 14 october 2017
Honorary award for CMO of Modra, Jan Schellens 25 september 2017
Modra Pharmaceuticals Announces Start of Phase II Study for its Lead Oral Chemotherapy in Patients with Metastatic Prostate Cancer 14 june 2017
Chemotherapy as a tablet instead of an intravenous infusion: a benefit for the patient 28 march 2017
Meet Us At 30 august 2017

Meet Us At

30 august 2017

Meet us at one of the following events:

 

BioCapital Europe 2018, February 6, 2018, Amsterdam, Netherlands

 

BIO-Europe Spring, March 12 -14, 2018, Amsterdam, Netherlands

 

 

 

 

 

 




News

Phase I results with ModraDoc006/r published in the European Journal of Cancer
Read more

the IV to Oral switch

improving patient lives
Learn more

Events

Meet us at one of the following events:      
Read more